Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gen, Yoshiya"'
Autor:
Mutsuo Sasaki, Gen Yoshiya, Atsushi Ishiguro, Takenori Takahata, Akihiro Munakata, Masato Saito, Yoshihiro Tamura
Publikováno v:
Journal of Gastroenterology and Hepatology. 21:1334-1339
Background and Aim: Genetic silencing by promoter methylation has attracted attention in the carcinogenesis of colorectal cancer. Methylation of the p16 INK4a gene has been found in primary colorectal cancer. Although the p15 INK4b gene displays high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5206cbc138f41b2cae79e98c8de8f51
https://doi.org/10.1111/j.1440-1746.2006.04137.x
https://doi.org/10.1111/j.1440-1746.2006.04137.x
Autor:
Gen Yoshiya, Takenori Takahata, Norio Yasui-Furukori, Tomonori Tateishi, Tsukasa Uno, Kazunobu Sugawara
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 94:252-256
An in vitro study has recently suggested that a proton pump inhibitor, omeprazole, is a modest substrate of P-glycoprotein. Several studies have shown P-glycoprotein is involved in the absorption and excretion of fexofenadine. Therefore, we examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f8c7d03090a11469e813d29ec263cc5
https://doi.org/10.1111/j.1742-7843.2004.pto940509.x
https://doi.org/10.1111/j.1742-7843.2004.pto940509.x
Autor:
Norio Yasui-Furukori, Sunao Kaneko, Tomonori Tateishi, Yoshimasa Inoue, Gen Yoshiya, Taku Nakagami, Takenori Takahata
Publikováno v:
British Journal of Clinical Pharmacology. 57:487-494
Omeprazole is mainly metabolized by the polymorphic cytochrome P450 (CYP) 2C19. The inhibitory effect of fluvoxamine, an inhibitor of CYP2C19 as well as CYP1A2, on the metabolism of omeprazole was compared between different genotypes for CYP2C19.Eigh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2d184ef2e92f40984119e175160a5f
https://doi.org/10.1111/j.1365-2125.2003.02047.x
https://doi.org/10.1111/j.1365-2125.2003.02047.x
Autor:
Shinsaku Fukuda, Naoyuki Hanada, Gen Yoshiya, Atsushi Ishiguro, Takenori Takahata, Mutsuo Sasaki, Kazuhiro Suzuki, Masato Saito
Publikováno v:
Journal of gastroenterology and hepatology. 23(6)
Background and Aim: Single nucleotide polymorphisms (SNP) are shown to be related with cancer incidence. It has been reported that CCND1, p21cip1DCC, MTHFR, and EXO1 are related with the risk of malignant neoplasm, but few studies have mentioned the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014722c1cc7430f017e8ac2d3bf4b62d
https://pubmed.ncbi.nlm.nih.gov/18565014
https://pubmed.ncbi.nlm.nih.gov/18565014
Autor:
Atsushi, Ishiguro, Takenori, Takahata, Masato, Saito, Gen, Yoshiya, Yoshihiro, Tamura, Mutsuo, Sasaki, Akihiro, Munakata
Publikováno v:
Journal of gastroenterology and hepatology. 21(8)
Genetic silencing by promoter methylation has attracted attention in the carcinogenesis of colorectal cancer. Methylation of the p16(INK4a) gene has been found in primary colorectal cancer. Although the p15(INK4b) gene displays high homology to the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a57d8c78d4271d2fab850f61bea56527
https://pubmed.ncbi.nlm.nih.gov/16872319
https://pubmed.ncbi.nlm.nih.gov/16872319
Autor:
Takenori, Takahata, Norio, Yasui-Furukori, Gen, Yoshiya, Tsukasa, Uno, Kazunobu, Sugawara, Tomonori, Tateishi
Publikováno v:
Basicclinical pharmacologytoxicology. 94(5)
An in vitro study has recently suggested that a proton pump inhibitor, omeprazole, is a modest substrate of P-glycoprotein. Several studies have shown P-glycoprotein is involved in the absorption and excretion of fexofenadine. Therefore, we examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8d062abe917a36b1108818e3ba8fb75
https://pubmed.ncbi.nlm.nih.gov/15125696
https://pubmed.ncbi.nlm.nih.gov/15125696